+44 (0) 20 7549 9987 | USA callers: +1 212 220 8419

Contact Us Now

“Global Clinical Trial Management System market forecast is expected to reach $4,805.6m by 2030” says new Visiongain report

17 March 2020
Pharma

Visiongain has launched a new pharma report Global Clinical Trial Management System Market.

The Global Market for Clinical Trial Management System is favoured by technological advancements and the rise of e-clinical platforms within clinical research organisations will continue to drive and take on more clinical trial projects. Continued market disruption by multiple industry forces such as advances in medicine, technology, and cost pressures will also allow now point solution vendors to distinguish themselves and their services over platform vendors. This dynamic will support ongoing diversity in the CTMS technology ecosystem even as the benefits of the CTMS platform continue to grow.

The lead analyst of the report commented "The clinical trials management system market is expected to witness a robust growth during the years of forecast owing to the rise in the number of clinical trials, rising investments in CTMS and advancements in technology. Clinical trial technology vendors have taken the pace of consolidating and incorporating technologies and resources into cloud-based e-clinical systems that support many clinical trial processes. Advanced technologies such as AI, better visualisations and analytics are enabling clients to unlock significant efficiencies in R&D. Having said this, many CROs are entering the CTMS space and increasingly developing their own solutions, this has led to talent poaching and increased competition on the market."

Leading companies featured in the report include Parexel Informatics Inc, Oracle, Medpace Holdings. Mednet Solutions, ERT Clinical, DataTRAK Internationals, Inc and many others.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034

The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.

23 April 2024

Read

Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034

The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.

18 April 2024

Read

Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034

The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.

17 April 2024

Read

Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.

12 April 2024

Read